Andrew Nixon, spokesperson for HHS, confirmed that the FDA was reviewing deaths potentially associated with the COVID-19 vaccine.
The FDA is "rigorously reviewing the available data" regarding the safety of 2 monoclonal antibody products for RSV in infants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback